In this podcast from Mobile in Clinical Trials 2018, Pfizer's Project Team Lead, Early Clinical Development, Digital Medicine, Dr Carrie Northcott speaks about considerations and lessons learned from the validation, verification and use of digital wearable technology in a Atopic Dermatitis Clinical Trial and some of Pfizer's forward-leaning work in decision making around novel digital endpoints. Dr Northcott is coming back to Mobile 2019 to share results and next steps on this trial. Speakers: C...
Aug 08, 2019•22 min
In this session presented at the Mobile in Clinical Trials 2018 conference, Merck's Kai Bode and Jyoti Shah share an exciting update on the company's progress in implementing a digital health and AI strategy. Session takeaways include: What Merck is doing in digital health and AIExternal collaborations on AISmart trial initiative to enable patient-centric studies Kai Bode is returning to Mobile 2019 to share an update on Merck's digital strategy 2.0 and how they are engineering for scale. Speake...
Aug 07, 2019•14 min
In this session from DPharm 2018, Roche provides an update on the company's progress in how they are collecting data with sensor technology and turning it into a clinically meaningful endpoint with multiple indications, including Parkinson's disease and Multiple Sclerosis. Session takeaways include: Understand what Digital Biomarker innovation means for the future of clinical development and potentially personalized healthcare.Be inspired to use mobile sensors technology in the context of clinic...
Jul 31, 2019•16 min
This is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical trials with the advancement of regenerative medicine, and how regenerative medicine can improve accuracy and speed up the clinical trial process. Speaker: Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine The 9th annual DPh...
Jul 30, 2019•31 min
This 4 minute podcast summarizes what you can expect at the 6th annual Mobile in Clinical Trials conference. This event provides sessions on the latest progress in applying mobile applications and patient-facing technologies to connect and empower patients, while obtaining better outcomes in drug development. The conference takes place September 16, 2019 at the Renaissance Boston Waterfront Hotel, Boston, MA. The program is co-chaired by Bayer’s Michelle Shogren, Director of Innovation, Pharma R...
Jul 29, 2019•4 min
An Insight into Our Possible Future Faster than You Think This keynote session was presented at the 2018 DPharm conference. Estonia is now a digital republic with a virtual government, blockchained and secure. Our keynote guest from Estonia tells us how Estonia became the fastest country in the world to go digital. Its 1.3 million citizens pay with their mobile phones, have their health records stored in the digital cloud, and filed their annual tax return online in five minutes. This session de...
Jul 29, 2019•35 min
In this session presented at the 2018 DPharm conference, Rob Goodwin and Amy Nordo share an exciting new collaboration - including industry and academia, as well as health authorities and leading technologists - positioned to break through the barriers to allow the power and the promise of eSource across companies and medical centers. The potential for eSource has been discussed for years, but realizing its promise has been difficult. While most health data today can be captured within electroni...
Jul 28, 2019•28 min
In this podcast from DPharm 2018, Pfizer's VP of Clinical Supply Chain, Michael Ku, speaks about some of Pfizer's earliest work making blockchain real as well as some of their forward-leaning work digitizing supply chain for clinical trials. The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.
Jul 27, 2019•21 min
In this podcast from DPharm 2018, Bayer shares how they use virtual assistants and chatbots to support study teams, research sites, and patients. Learn how they are doing this and what you should consider. Speaker: Michelle Shogren, Head of Innovation, Portfolio & Operations, Bayer The 9th annual DPharm conference will take place on September 17-18 in Boston, MA. Learn more at theconferenceforum.org.
Jul 26, 2019•15 min
In this podcast, Valerie Bowling, Director of DPharm, walks you through what to expect at DPharm 2019 in under 5 minutes. This is the 9th annual DPharm conference featuring keynotes from: Dr Scott Gottlieb, 23rd Commissioner of the FDATakeda’s CMO, Dr Andy PlumpMerck’s VP of Global Operations, Dr Mark TraversCellarity's Chief Data Officer, Milind KamkolkarStarbucks' Design Director of Global Digital Products, Robert MercerFast Company's Deputy Editor, David LidskyHealthgrades' Founder, Kerry Hic...
Jul 25, 2019•5 min
Trialspark, CEO, Dr Ben Liu recently sat down with Valerie Bowling, Executive Director of DPharm in a podcast discussion. Valerie checked in with Ben on the progress of life as a data science entrepreneur. They also discussed how Ben and his team are solving big challenges in drug development, new evolving R&D models and more. On Sept 17th, Ben will be interviewing Pfizer's Rod Mackenzie, Chief Development Officer at DPharm: Disruptive Innovations to Advance Clinical Trials in Boston. For mo...
Jul 23, 2019•19 min
When developing technologies to solve medical problems, one often encounters significant hurdles, that at times seems insurmountable. In this discussion, recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Dr Jeffrey Karp, Professor of Medicine, Harvard Medical School and Director of the Laboratory for Accelerated Medical Innovation, Brigham and Women's Hospital discusses overcoming these hurdles with the use of nature for inspiration. This talk will explore ...
Jul 22, 2019•27 min
In this industry keynote recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Justin Wright, PhD, Global Head of Innovation, Novartis, discusses how the transformation from traditional drugs to next-generation product systems, where sometimes the drug is only a component of the overall product offering, is creating a opportunity for non-traditional competitors and start-ups to access the market and potentially redefine the value model associated with drug pric...
Jul 21, 2019•24 min
In this podcast from DPharm 2018, Chip Bell shows pragmatic ways to change our culture to support service-oriented thinking that benefits patients and investigators. The patient's expectations are being quickly changed today by disruptors far beyond the Pharma industry. How will the concept of service make us better at drug development and help us become more disruptive thinkers? Speaker: Chip Bell, PhD, Keynote Innovative Service Speaker, Author, Senior Partner, The Chip Bell Group The 9th annu...
Jul 21, 2019•46 min
Moderated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference explores how mRNA vaccines represent a promising alternative to conventional vaccine approaches for infectious diseases as well as oncology indications, including an emerging application for personalized cancer vaccines. The panelists for the session are: Örn Almarsson, PhD, Head of Formulations...
Jul 20, 2019•37 min
This session was presented at the 8th annual DPharm conference in September 2018. When Amazon announced that the creation of a new healthcare company with Berkshire Hathaway and JPMorgan Chase, the move signaled how the company is stepping into the healthcare industry. However, Amazon Web Services (AWS) has been working directly with the healthcare and life science industries for quite some time. Life Science Director, Mark Johnston, shares how AWS thinks about innovation, in particular for the ...
Jul 11, 2019•40 min
Roughly, 5.7 million people in the U.S. are living with Alzheimer’s. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain symptoms for some people. Research studies so far have a poor record. Patients can face incredible enrollment hurdles in clinical trials. A Patient Registry can be very useful in identifying patients. A registry can also address the original problem statement about failed trials. A robust, living reg...
Jun 25, 2019•29 min
This 8 minute podcast summarizes what you can expect at the 4th annual IO Combinations 360° conference. This conference provides the latest data impacting immuno-oncology combinations and patient treatment with perspectives from science, clinical and business. The conference takes place June 20-21, 2019 at the Wyndham Philadelphia Historic District, Philadelphia, PA. For more information please visit www.theconferenceforum.org or contact us at service@tcfllc.org
May 23, 2019•8 min
Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania focuses on the next steps for CAR-T therapy for cancer, discussing the novel approaches that are being developing in Dr Carl June’s lab including CAR-T combinations with small molecules and gene-editing. Save the date for IO Combinations 360° happening June ...
May 02, 2019•19 min
The hardest thing to figure out now is what interventions and combinations make the most sense in which patients and how to combine all these emerging modalities in a way that is cost effective, benefits patients and unfolds in our lifetime. There are hypothesis on what technologies should be explored together, however very few companies have all the relevant skills, reagents or product candidates in one setting, so it requires collaboration to generate the most powerful combinations and sequenc...
May 01, 2019•39 min
In this panel, moderated by Dr Axel Hoos, GSK, individuals from large pharma and biotech business development leads discuss decision-making when it comes to partnering and collaborations in today’s IO environment. What is the current nature and types of partnerships being done in IO?Is dealmaking and partnerships evolving due to the need for IO combinations? How so?What is the balance between in house R&D and external innovation in IO?What is the decision making regarding exclusive licensing...
Apr 30, 2019•52 min
This panel, moderated by Dr Priti Hegde, Genentech, discusses the following: How can biomarkers act as a tool for understanding the biology at a level that is sufficient for making decisions around combinations?What are the potential biomarkers that can help predict if a patient will respond to combinations?Once a biomarker is identified in terms of biology, been measured and the technology platform identified to meet those measures, how is the biomarker developed to the level of clinical grade ...
Apr 29, 2019•38 min
In this podcast, Dr Gregory Goldmacher, Executive Director, Translational Biomarkers and Head of Clinical Imaging, Merck Research Labs along with Dr Matthew Silva, Executive Vice President, Scientific Applications, Invicro discuss innovations in IO imaging. Together, Dr Goldmacher and Dr Silva address: The evolution of treatment response criteria in immuno-oncologyNovel Tracers: Monitoring tumor or immune cell populations with imagingRadiomics, AI and Digital Biomarkers Join us February 26-28, 2...
Apr 25, 2019•33 min
The 2nd annual Drug Delivery West (DDW) Summit provides a west coast venue for biotech, pharma and drug delivery companies to address scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care. This podcast discusses who will be presenting and the topics covered at the summit taking place May 6-7, 2019 at the Marines' Memorial Club and Hotel in San Franci...
Apr 05, 2019•5 min
Modernizing Clinical Trials with IQVIA's Dr Cynthia Verst Host: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm:Disrupting Clinical Trials Guest: Dr Cynthia Verst, President, Design and Delivery Innovation for the Research & Development Solutions organization at IQVIA
Apr 01, 2019•25 min
In this podcast, Valerie Bowling, Executive Director of the Conference Forum, interviews Dr Laura Esserman, breast cancer surgeon and researcher at the University of California, San Francisco. Dr Esserman shares her thoughts on how we can move towards uniting care and clinical research and the future of how medicine should be practiced.
Mar 27, 2019•8 min
This discussion was presented at the inaugural Drug Delivery West conference in 2018. One of the key challenges in global health is ensuring safe and effective delivery of life saving interventions to remote and non-clinical settings. The Bill & Melinda Gates Foundation invests in technologies, which will help achieve this goal. Learn about an RFP they are launching to indentify new ideas for delivering lyophilized products and how you can participate. Presented by David Robinson, PhD, Deput...
Mar 04, 2019•12 min
This panel, presented at the inaugural Drug Delivery West conference in 2018, provides patient perspectives on what they want from drug delivery technologies. These case examples provide insight that every technology can benefit from and lessons learned through our patient representatives. Co-Moderators: Valerie Bowling, Patient Advocate and Executive Director, Drug Delivery West Sudeshna Dutta Ray, Senior Engineer, Advanced Device Technology and Innovation, Amgen Panelists: Cynthia Goldstein, P...
Feb 25, 2019•42 min
In this discussion, CRAACO co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, and Alison Bateman-House, PhD, MPH, MA, Assistant Professor Division of Medical Ethics, NYU Langone Health, consider what lines are being drawn in the integration of clinical care and clinical research. More specifically: Research and care or treatment are separate spheres in the regulatory and ethical worlds. What happens when they are brought together?Are there ethical barriers that need to be...
Feb 06, 2019•35 min
In this discussion, stakeholders from medical practices, hospitals, service providers, and patient advocacy discuss how medical practices can offer clinical trials to patients. Including: Infrastructure and supportHow to establish physician championsHow to influence leadership supportContacting patients Moderated by: Jennifer Byrne, Founder, Greater Gift Initative Panelists: Judy Hung, MD, Director Trial Innovation Unit, Division of Clinical Research, Massachusetts General Hospital Jeff James, C...
Feb 05, 2019•41 min
